Primary Peritoneal Carcinoma Completed Phase 2 Trials for Docetaxel (DB01248)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00214058Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal CancerTreatment